The Special Interest Groups progress collaborative opportunities to support the growth of the life sciences sector in Wales. Bringing together industry, NHS, academia and other partner organisations to drive forward a change in the way healthcare is delivered, the SIGs have the potential to progress curative treatments for a range of disease areas.
Cell and Gene Therapy Special Interest Group
The Cell and Gene Therapy Special Interest Group was established in 2016 to build a dynamic and successful Cell and Gene Therapy and Regenerative Medicine cluster in Wales. Led by the Welsh Blood Service, stakeholders and funding agencies include the Cell and Gene Therapy Catapult, Welsh Government and Innovate UK. In 2018 the Cell and Gene Therapy Special Interest Group supported a health consortium, which was awarded £7.3m of UK Government funding. The funding will help establish The Midlands & Wales Advanced Therapy Treatment Centre (MW-ATTC), which will facilitate future adoption of transformative cell and gene therapies within the UK.
The success of the Cell and Gene Special Interest Groupis attributed to the Group’s focus on delivery. Chaired by the Welsh Blood Service and orchestrated by us, this group is supporting NHS Wales priorities by:
- supporting the development of a Cell and Gene therapy strategy for Wales
- securing Innovate UK funding to establish a regional Cell and Gene treatment centre
- encouraging collaboration to identify solutions to shared challenges.
"I'm excited about the way in which the Life Sciences Hub Wales will be able to help us make the most of the opportunities from developments in science and technology for the people of Wales."
Cath O’Brien, Director of the Welsh Blood Service